Vimarsana
Biggest News Aggregation in the World

Page 2 - Et Cest News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Et Cest. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Et Cest Today - Breaking & Trending Today

Nordea Bank Abp: Transaction in Own Shares - Vimarsana News

Nordea Bank Abp: Transaction in Own Shares

Nordea Bank Abp / Key word(s): Transaction in Own Shares Nordea Bank Abp: Transaction in Own Shares 10.10.2023 / 08:00 CET/CEST Nordea Bank Abp: Repurchase of own shares on 09.10.2023 Nordea Bank Abp Stock exchange release - Changes in company's own shares 09.10.2023 at 22.30 EET Nordea Bank Abp...

Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone - Vimarsana News

Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone

Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone 10-Oct-2023 / 07:00 CET/CEST Release of an ad hoc a...

IGEA Pharma N.V.: IGEA to update on RBCARE business combination - Vimarsana News

IGEA Pharma N.V.: IGEA to update on RBCARE business combination

IGEA Pharma N.V. / Key word(s): Letter of Intent/Letter of Intent IGEA Pharma N.V.: IGEA to update on RBCARE business combination 09-Oct-2023 / 22:50 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.     FOR R...

EQS-News: Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis - Vimarsana News

EQS-News: Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

Issuer: Immunic, Inc. / Key word(s): Study results Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis 09.10.2023 / 22:01 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Reports Positi...

EQS-News: Steinhoff International Holdings N.V. in liquidatie: DE-LISTING TIMELINE - Vimarsana News

EQS-News: Steinhoff International Holdings N.V. in liquidatie: DE-LISTING TIMELINE

EQS-News: Steinhoff International Holdings N.V. in liquidatie / Key word(s): Miscellaneous Steinhoff International Holdings N.V. in liquidatie: DE-LISTING TIMELINE 10.10.2023 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. Shareholders are referred to the ...